|
|
||||||||
Departments of 1 Cardiovascular Medicine and 2 Physiology, Graduate School of Medicine, University of Tokyo, Tokyo 113-8655, 3 St. Luke's College of Nursing, Tokyo 104-0044; 4 Division of Cardiovascular Biology and 6 Department of Physiology, Chiba University School of Medicine, Chiba 260-8670; and 5 The Hospital International Medical Center of Japan, Tokyo 162-8655, Japan
| |
ABSTRACT |
|---|
|
|
|---|
Endothelin (ET)-1 is a 21-amino acid peptide that induces a variety of biological activities, including vasoconstriction and cell proliferation, and its likely involvement in cardiovascular and other diseases has recently led to broad clinical trials of ET receptor antagonists. ET-1 is widely distributed in the central nervous system (CNS), where it is thought to regulate hormone and neurotransmitter release. Here we show that CNS responses to emotional and physical stressors are differentially affected in heterozygous ET-1-knockout mice, which exhibited diminished aggressive and autonomic responses toward intruders (emotional stressors) but responded to restraint-induced (physical) stress more intensely than wild-type mice. This suggests differing roles of ET-1 in the central pathways mediating responses to different types of stress. Hypothalamic levels of ET-1 and the catecholamine metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) were both increased in wild-type mice subjected to intruder stress, whereas MHPG levels were not significantly affected in ET-1-knockout mice. Furthermore, immunohistochemical analysis showed that ET-1 and tyrosine hydroxylase, an enzyme in the catecholamine synthesis pathway, were colocalized within certain neurons of the hypothalamus and amygdala. Our findings suggest that ET-1 modulates central coordination of stress responses in close association with catecholamine metabolism.
knockout mice; catecholamine
| |
INTRODUCTION |
|---|
|
|
|---|
RESPONSES TO ENVIRONMENTAL stressors involve activation of complex central nervous system (CNS) pathways leading from stress perception to behavioral, autonomic, and endocrine responses. As represented by Selye's adaptation syndrome, general responses to stressors can lead to pathophysiological changes and may thus provide a pathogenic basis for such diseases as hypertension and ischemic heart disease (9, 35). The hypothalamus and limbic system, including the amygdala, are thought to integrate stressor-evoked signals into such physiological responses. In addition, accumulating evidence indicates that neuroendocrine factors, such as catecholamines, corticotrophin-releasing hormone (CRH), serotonin, and vasopressin function within the central circuits mediating stress responses (3, 4, 8, 32, 34, 36, 39, 40); however, the precise allocation of these factors within neuroanatomical structures and their mutual interactions have not been fully explored.
Endothelin-1 (ET-1) is a 21-amino acid peptide that was first identified as a vasoconstrictor in the supernatant of cultured vascular endothelial cells (42). Three isopeptides (ET-1, -2, and -3) encoded by separate gene loci constitute a gene family whose products act via two distinct G protein-coupled receptors (ET-A and ET-B) with differing affinities (26, 28, 33, 41). In addition to its vasoconstrictor effects on vascular smooth muscle cells, in other cell types, ET-1 exhibits a diverse set of biological activities, including stimulation of proliferation and modulation of hormone release (26, 28, 33, 41). In the CNS, ET-1 expression is widely distributed in the cerebral cortex, striatum, hippocampus, amygdala, pituitary gland, supraoptic and paraventricular nuclei of the hypothalamus, cerebellar Purkinje cells, raphe nuclei, dorsal motor nucleus of the vagus nerve and the dorsal horn, and intermediolateral cell column in the spinal cord (6, 25, 38, 43). The expression pattern of ET-1 and its effects on the release of various neuropeptides (26, 28, 33, 41, 43) suggests that it may serve as a neurotransmitter and/or neuromodulator within the CNS. When we used gene targeting to disrupt the mouse Edn 1 locus encoding ET-1 (17), the resultant mice homozygous for the ET-1 null mutation exhibited morphological abnormalities in cranial neural crest-derived craniofacial tissues and organs (16, 17). Our further analysis of these ET-1-knockout mice revealed the central role of ET-1 in the autonomic nervous regulation of cardiopulmonary homeostasis (17, 18, 22, 23, 27). Moreover, the high levels of ET-1 expression in the hypothalamus and limbic system and the close association between ET-1 and central and peripheral sympathetic nerve activity (15, 18-23, 27, 29) led us to hypothesize that ET-1 plays a significant role in stress responses. In the present study, we tested this hypothesis by applying stress-inducing stimuli to ET-1-knockout mice and analyzing selected behavioral, autonomic, and neurochemical responses.
| |
METHODS |
|---|
|
|
|---|
Mice. ET-1-knockout mice were established by gene targeting as previously described (17). After extensive backcross breeding, the genetic background had been altered to ICR or to C57B6. Most experiments were performed using mice with the ICR background; for the restraint stress test, however, mice with the genetic background of the 129Sv/J × ICR hybrid were used. The mice were housed in a room maintained at 25°C on a light-dark cycle (lights were on from 0900 to 2100) and were fed a normal diet and water ad libitum. Only males were used in this study.
Resident-intruder test. Heterozygous ET-1-knockout mice and their wild-type litter mates (10-14 wk old) were housed as isolated individuals for 4 wk. On the day of experimentation, each mouse (resident) in its home cage was placed on top of a radio receiver (RLA1020; Data Sciences). Telemetric monitoring of electrocardiogram (ECG) and body temperature was then accomplished using a radio transmitter (TA10ETA-F20; Data Sciences) implanted in advance in the abdominal cavities of the animals under halothane anesthesia. After baseline parameters were measured for 10 min, a group-housed, wild-type mouse (intruder) was placed in the cage for 5 min. Behavioral responses of the resident, namely latency before attack of the intruder and the number of attacks, were observed through a transparent wall of the cage. The ECG and body temperature of the resident was continuously monitored throughout the experimental period and processed using a computer-assisted data acquisition system (Dataquest IV; Data Sciences) that yielded values for heart rate and body temperature every 1 min. Tests were repeated after an interval of 1 wk, in the same individuals when possible.
Restraint test. A femoral artery in each animal was cannulated with a polyethylene tube under halothane anesthesia as previously described (17). Beginning on the day after the surgery, arterial blood pressure and heart rate were monitored continuously through the cannula using a pressure transducer (AP601G; Nihon Koden) and a tachometer (AT600G; Nihon Koden), respectively. Initially, baseline parameters were measured for 10 min in the awake, unrestrained animals, after which the mice were placed in a narrow stainless steel mesh tube (2.5 cm in diameter) for 10 min. Mean arterial blood pressure was obtained by passing the instantaneous blood pressure signal through a low-pass filter (corner frequency 0.2 Hz) while heart rate signals were sampled at the rate of 1 Hz using an analog-to-digital converter (MacLab/16s; ADInstruments). The mean values for these variables over periods of successive 2-, 5-, or 10-min intervals were then calculated by computer (Power Macintosh 9500/120; Apple Computer).
Immunohistochemistry. Mice were anesthetized with ether and perfused with Zamboni's solution. The brains were dissected, prefixed, embedded in OCT compound, and serially cut into 10-ìm frozen sections using a cryostat. Slide-mounted tissue sections were washed with PBS, treated with 0.3% H2O2 in methanol, preincubated with goat nonimmune serum, and incubated with rabbit anti-ET-1 polyclonal antibody for 2 days at 4°C (43). The sections were then incubated with biotinylated goat anti-rabbit IgG (Immuno-Biological Laboratories) for 1 h at 37°C. After washing, the sections were treated with avidin-biotinylated horseradish peroxidase complex (Vectastain ABC kit, Vector Labs) and developed with 0.004% H2O2 and 0.02% diaminobenzidine tetrahydrochloride. Double-label immunostaining was accomplished by first treating sections with rabbit anti-ET-1 polyclonal antibody followed by incubation with rhodamine-conjugated swine anti-rabbit IgG (Dako) for 1 h at 37°C. The sections were then treated with anti-tyrosine hydroxylase (Chemicon) or anti-glial fibrillary acidic protein (GFAP) monoclonal antibody for 1 h at 37°C and stained with fluorescein-labeled horse anti-mouse IgG (Dako) for an additional 1 h. Samples were examined under a MRC1024 confocal laser scanning microscope (BioRad).
Measurement of ET-1 and MHPG levels.
The brains of mice just subjected to the resident-intruder test (see
Resident-intruder test) and of untreated controls were fixed
by applying microwave radiation (5 kW; model TMW6402C; Toshiba) to
their heads for 1.2 s. The brain tissue was then removed and dissected (7), isolating the hypothalamus and medulla
oblongata, which were weighed and stored at
80°C until use. ET-1
levels in tissue homogenates were measured by enzyme-linked
immunosorbent assay. Tissue contents of a noradrenaline metabolite,
3-methoxy-4-hydroxyphenylglycol (MHPG), were measured with
high-performance liquid chromatography.
Statistical analysis. Gehan-Wilcoxon's nonparametric test was used to compare attack latency during the resident-intruder test; attack numbers were compared using Student's t-test. Heart rates, arterial blood pressures, and body temperatures were analyzed using repeated-measures ANOVA. ET-1 and MHPG levels were compared using Student's t-test and two-factor (genotype × stress) ANOVA, respectively; the latter was carried out using the Statistica statistics package (StatSoft; detailed explanation of the method and references are supplied in the manufacturer's manual). Quantitative data were expressed as means ± SE. Values of P < 0.05 were considered significant.
| |
RESULTS |
|---|
|
|
|---|
Impaired stress responses in ET-1-knockout mice.
To investigate the role of ET-1 in the central circuits mediating
behavioral responses to emotional stress, we performed
resident-intruder tests in which the latency before attacking an
intruder and the frequency of the attacks was assessed. When confronted
with an intruder, resident heterozygous ET-1-knockout mice (ICR
background) were slower to attack the intruder (Fig.
1A) and attacked less frequently (Fig. 1B) than their wild-type litter
mates. Increased aggressiveness and intensity of attack,
presumably due to fighting experience, was noted in both groups during
a second test carried out 1 wk later (Fig. 1, A and
B). Similar results were obtained using mice with the C57B6
background, although they were generally less aggressive than mice with
the ICR background (data not shown).
|
|
Stress-induced changes in brain ET-1 levels associated with
catecholamine metabolism.
Catecholamines are among the factors known to play major roles in
central stress responses. To investigate whether ET-1 production is
affected by stress and to compare it with catecholamine metabolism, we
measured hypothalamic ET-1 and MHPG and found that both were significantly elevated in wild-type mice during the resident-intruder test (Fig.
3,
A and B). The increase in MHPG is consistent with earlier findings demonstrating the role of hypothalamic catecholamine metabolism in the central processing of stress responses
(11, 30). The increase in hypothalamic ET-1
levels in ET-1-knockout heterozygotes, whose basal ET-1 levels in the
hypothalamus were ~70% of those of wild-type litter mates, was not
significant (Fig. 3A). Furthermore, the stress-induced
increase in hypothalamic MHPG was significantly diminished in
ET-1-knockout mice (Fig. 3B).
|
-receptors (37).
Expression of ET-1 in the brain.
Expression of ET-1 in the brain was examined immunohistochemically.
Intense immunoreactive (ir) ET-1 signaling was detected in the
hypothalamic paraventricular nucleus and in the amygdala (Fig.
4), both of which are involved in
coordinating stress responses (24). Many but not all
irET-1-positive cells were small in size and were identified as glial
cells by colocalization with GFAP, a glial cell marker (data not
shown). Double labeling revealed that many irET-1-positive neurons in
the hypothalamus and amygdala were also positive for tyrosine
hydroxylase, an enzyme in the catecholamine synthesis pathway (Fig. 4).
Thus ET-1 and catecholamines are coexpressed within certain neurons
situated in centers coordinating stress responses.
|
| |
DISCUSSION |
|---|
|
|
|---|
Confrontation with an intruder evokes aggressive responses accompanied by sympathetic neural and humoral activation in some animals, including mice housed in isolation. This response has served as a useful experimental model of emotional stress and has been applied to various genetically engineered animals to clarify the molecular mechanisms responsible for central stress responses (34, 39). In the present study, we demonstrate that the responses to an intruder were significantly diminished in ET-1-knockout mice. Because stress-induced behavioral and autonomic responses as well as increases in hypothalamic catecholamine metabolism were all impaired in ET-1-knockout mice, we suggest that ET-1 plays a significant role in the coordination of central stress responses in the hypothalamus and limbic system and that ET-1 may even directly regulate catecholamine-mediated signaling. In contrast, the response to the physical stress imposed by restraint within a narrow tube was augmented in ET-1-knockout mice, suggesting that vagal inhibition of the stress-mediating neural circuit may also be impaired in ET-1-knockout mice.
Several pieces of evidence support the notion that ET-1 is involved in CNS functions related to stress responses. For example, ET-1 is widely expressed throughout the CNS, including in the limbic system and the hypothalamus (6, 25, 38, 43). Moreover, ET receptors are distributed in those regions of the forebrain, cerebellum, and brain stem where ET-1 is expressed (5, 10, 13, 14). Intracerebroventricular administration of ET-1 or ET-3 evokes changes in sympathetic nerve activity and in behavioral responses such as barrel rotation (13, 29) and evokes c-fos expression in the ventrolateral septum, stria terminalis, paraventricular hypothalamic nucleus, and central amygdaloid nucleus (44). This pattern is similar to that induced by intracerebroventricular infusion of vasopressin or CRH (1), neuropeptides also implicated in stress responses (3, 8, 32, 36, 39, 40). In the context of these earlier studies, the present results suggest that participation by ET-1 in the central responses to emotional and physical stresses involves modulation of separate CNS pathways.
When mice were subjected to intruder stress, hypothalamic levels of ET-1 and MHPG were both increased in wild-type mice, but no change in MHPG levels was observed in ET-1-knockout mice, suggesting that ET-1- and catecholamine-mediated signaling are sequentially activated in response to stress. In fact, ET-1 and ET-3 have been shown to induce catecholamine release from striatal slice (12) and adrenomedullary chromaffin cells (2). Furthermore, ET-1 colocalized with tyrosine hydroxylase in some neurons of the hypothalamus and amygdala. Although there is presently no direct evidence for the involvement of cells coexpressing ET-1 and catecholamines in central stress responses, our findings make it reasonable to hypothesize that activation of ET-1-catecholamine pathways in the hypothalamus and amygdala contributes significantly to that process.
We previously showed that heterozygous ET-1-knockout mice have high blood pressure that is primarily attributable to excessive sympathetic activity, whereas baroreflex control of heart rate was not affected (17, 18, 22, 23, 27). This may seem to contradict the present finding of the relationship between ET-1 and catecholamines in stress responses, but it is likely that the relationship between ET-1 and catecholamines varies among different regions in the CNS. For instance, within the medulla oblongata, topical administration of ET-1 elicits differing effects on sympathetic nerve activity depending on the specific sites of administration (19), indicating that ET-1 acts on both the stimulatory and inhibitory pathways involved in central control of sympathetic activity.
The present findings are also important in practical terms, because ET antagonism is now likely to emerge as an important therapeutic strategy for the treatment of several cardiovascular and other diseases. Indeed, despite the fact that the chronic effects of these antagonists on ET metabolism and function in the CNS have not been fully investigated, a number of ET receptor antagonists are currently undergoing clinical trails. Our findings indicate that a chronic ~50% reduction in systemic ET-1 production, including in the brain, can result in significant changes in the pathways mediating central stress processing. Evaluation of the effects of chronic administration of ET receptor antagonists on CNS function would thus seem warranted.
In conclusion, ET-1 has emerged as a potentially important modulator of stress responses in the CNS. Nonetheless, further analysis of the relationship between the ET and catecholamine systems, as well as between ET-1 and other factors, such as CRH, vasopressin, and serotonin, will be necessary before a complete understanding of the CNS pathways mediating stress is achieved.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Takeshi Iwatsubo (University of Tokyo) for helpful advice and discussion and Dr. Takamura Muraki (Tokyo Women's Medical University) for technical support.
| |
FOOTNOTES |
|---|
* Y. Kurihara, H. Kurihara, and T. Kuwaki contributed equally to this work.
Y. Kurihara is a Research Fellow in the Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Drug ADR Relief, Research and Development Promotion and Product Review of Japan.
This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan; the Japan Cardiovascular Research Foundation; the Kanae Foundation of Research for New Medicine; Tanabe Medical Frontier Conference; Suzuken Memorial Foundation; the Ryoichi Naito Foundation for Medical Research; Tokyo Biochemical Research Foundation; the Naito Foundation; the Takeda Science Foundation and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to H. Kurihara and T. Kuwaki).
Address for reprint requests and other correspondence: H. Kurihara, Dept. of Cardiovascular Medicine, Graduate School of Medicine, Univ. of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan (E-mail:kuri-tky{at}umin.ac.jp).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Received 10 December 1999; accepted in final form 29 February 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Andreae, LC,
and
Herbert J.
Expression of c-fos in restricted areas of the basal forebrain and brainstem following single or combined intracerebroventricular infusions of vasopressin and corticotrophin-releasing factor.
Neuroscience
53:
735-748,
1993[Web of Science][Medline].
2.
Boarder, M,
and
Marriott D.
Endothelin-1 stimulation of noradrenaline and adrenaline release from adrenal chromaffin cells.
Biochem Pharmacol
41:
521-526,
1991[Web of Science][Medline].
3.
Borrelli, E.
A chilled-out knockout.
Nat Genet
19:
108-109,
1998[Web of Science][Medline].
4.
Davis, M,
Rainnie D,
and
Cassell M.
Neurotransmission in the rat amygdala related to fear and anxiety.
Trends Neurosci
17:
208-214,
1994[Web of Science][Medline].
5.
Fuxe, K,
Anggard E,
Lundgren K,
Cintra A,
Agnati LF,
Galton S,
and
Vane J.
Localization of [125I]endothelin-1 and [125I]endothelin-3 binding sites in the rat brain.
Acta Physiol Scand
137:
563-564,
1989[Web of Science][Medline].
6.
Giaid, A,
Gibson SJ,
Ibrahim BN,
Legon S,
Bloom SR,
Yanagisawa M,
Masaki T,
Varndell IM,
and
Polak JM.
Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia.
Proc Natl Acad Sci USA
86:
7634-7638,
1989
7.
Glowinski, J,
and
Iversen L.
Regional studies of catecholamines in the rat brain.
J Neurochem
13:
622-669,
1966.
8.
Henry, JP.
Psychological and physiological responses to stress: the right hemisphere and the hypothalamo-pituitary-adrenal axis, an inquiry into problems of human bonding.
Acta Physiol Scand
640:
10-25,
1997[Medline].
9.
Henry, JP,
Stephens PM,
and
Santisteban GA.
A model of psychological hypertension showing reversibility and progression of cardiovascular complications.
Circ Res
36:
156-164,
1974
10.
Jones, CR,
Hiley CR,
Pelton JT,
and
Mohr M.
Autoradiographic visualization of the binding sites for [125I]endothelin in rat and human brain.
Neurosci Lett
97:
276-279,
1989[Web of Science][Medline].
11.
Kohno, Y,
Tanaka M,
Nakagawa R,
Toshima N,
and
Nagasaki N.
Regional distribution and production rate of 3-methoxy-4-hydroxyphenylethyleneglycol sulphate (MHPG-SO4) in rat brain.
J Neurochem
36:
286-289,
1981[Web of Science][Medline].
12.
Koizumi, S,
Kataoka Y,
Niwa M,
and
Kumakura K.
Endothelin-3 stimulates the release of catecholamine from cortical and striatal slices of the rat.
Neurosci Lett
134:
219-222,
1992[Web of Science][Medline].
13.
Koseki, C,
Imai M,
Hirata Y,
Yanagisawa M,
and
Masaki T.
Autoradiographic localization of [125I]-endothelin-1 binding sites in rat brain.
Neurosci Res
6:
581-585,
1989[Web of Science][Medline].
14.
Koseki, C,
Imai M,
Hirata Y,
Yanagisawa M,
and
Masaki T.
Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide?
Am J Physiol Regulatory Integrative Comp Physiol
256:
R858-R866,
1989
15.
Kumagai, H,
Suzuki H,
Ichikawa M,
Nishizawa M,
Oshima N,
and
Saruta T.
Interaction between endothelin and nitric oxide in sympathetic nerve modulation in hypertensive rats.
Hypertens Res
20:
35-42,
1997[Medline].
16.
Kurihara, Y,
Kurihara H,
Oda H,
Maemura K,
Nagai R,
Ishikawa T,
and
Yazaki Y.
Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1.
J Clin Invest
96:
293-300,
1995.
17.
Kurihara, Y,
Kurihara H,
Suzuki H,
Kodama T,
Maemura K,
Nagai R,
Oda H,
Kuwaki T,
Cao W-H,
Kamada N,
Jishage K,
Ouchi Y,
Azuma S,
Toyoda Y,
Ishikawa T,
Kumada M,
and
Yazaki Y.
Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1.
Nature
368:
703-710,
1994[Medline].
18.
Kuwaki, T,
Cao W-H,
Kurihara Y,
Kurihara H,
Ling G-Y,
Onodera M,
Ju K-H,
Yazaki Y,
and
Kumada M.
Impaired ventilatory responses to hypoxia and hypercapnia in mutant mice deficient in endothelin-1.
Am J Physiol Regulatory Integrative Comp Physiol
270:
R1279-R1286,
1996
19.
Kuwaki, T,
Cao W-H,
Unekawa M,
Terui N,
and
Kumada M.
Endothelin-sensitive areas in the ventral surface of the rat medulla.
J Auton Nerv Syst
36:
149-158,
1991[Web of Science][Medline].
20.
Kuwaki, T,
Koshiya N,
Cao W-H,
Takahashi H,
Terui N,
and
Kumada M.
Modulatory effects of endothelin-1 on central cardiovascular control in rats.
Jpn J Physiol
40:
827-841,
1990[Web of Science][Medline].
21.
Kuwaki, T,
Koshiya N,
Takahashi H,
Terui N,
and
Kumada M.
Modulatory effects of rat endothelin on central cardiovascular control in rats.
Jpn J Physiol
40:
97-116,
1990[Web of Science][Medline].
22.
Kuwaki, T,
Kurihara H,
Cao W-H,
Kurihara Y,
Unekawa M,
Yazaki Y,
and
Kumada M.
Physiological role of brain endothelin in the central autonomic control: from neuron to knockout mice.
Prog Neurobiol
51:
545-579,
1997[Web of Science][Medline].
23.
Kuwaki, T,
Kurihara Y,
Kurihara H,
Yazaki Y,
and
Kumada M.
Role of endothelin in central cardiorespiratory control: modern and classical approaches.
News Physiol Sci
10:
228-233,
1995
24.
LeDoux, JE.
Emotion, memory and the brain.
Sci Am
270:
50-57,
1994[Web of Science][Medline].
25.
Lee, M-E,
de la Monte SM,
Ng SC,
Bloch KD,
and
Quertermous T.
Expression of the potent vasoconstrictor endothelin in the human central nervous system.
J Clin Invest
86:
141-147,
1990.
26.
Levin, ER.
Endothelins.
N Engl J Med
333:
356-363,
1995
27.
Ling, GY,
Cao W-H,
Onodera M,
Ju K-H,
Kurihara H,
Kurihara Y,
Yazaki Y,
Kumada M,
Fukuda Y,
and
Kuwaki T.
Renal sympathetic nerve activity in mice: comparison between mice and rats and between normal and endothelin-1 deficient mice.
Brain Res
808:
238-249,
1998[Web of Science][Medline].
28.
Masaki, T.
Possible role of endothelin in endothelial regulation of vascular tone.
Ann Rev Pharmacol Toxicol
35:
235-255,
1995[Web of Science][Medline].
29.
Ouchi, Y,
Kim S,
Souza AC,
Iijima S,
Hattori A,
Orimo H,
Yoshizumi M,
Kurihara H,
and
Yazaki Y.
Central effect of endothelin on blood pressure in conscious rats.
Am J Physiol Heart Circ Physiol
256:
H1747-H1751,
1989
30.
Pacák, K,
Palkovits M,
Kvetnansky R,
Yadid G,
Kopin IJ,
and
Goldstein DS.
Effects of various stressors on in vivo norepinephrine release in the hypothalamic paraventricular nucleus and on the pituitary-adrenocortical axis.
Ann NY Acad Sci
771:
115-130,
1995[Web of Science][Medline].
31.
Pascoe, JP,
and
Kapp BS.
Electrophysiological characteristics of amygdaloid central nucleus neurons during Pavlovian fear conditioning in the rabbit.
Behav Brain Res
16:
117-133,
1985[Web of Science][Medline].
32.
Roozendaal, B,
Koolhaas JM,
and
Bohus B.
The role of the central amygdala in stress and adaptation.
Acta Physiol Scand
640:
51-54,
1997.
33.
Rubanyi, GM,
and
Polokoff MA.
Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.
Pharmacol Rev
46:
325-415,
1994[Web of Science][Medline].
34.
Saudou, F,
Amara DA,
Dierich A,
LeMeur M,
Ramboz S,
Segu L,
Buhot MC,
and
Hen R.
Enhanced aggressive behavior in mice lacking 5-HT1B receptor.
Science
265:
1875-1878,
1994
35.
Selye, H.
The general adaptation syndrome and diseases of adaptation.
J Clin Endocrinol Metab
6:
117-230,
1946
36.
Smith, GW,
Aubry JM,
Dellu F,
Contarino A,
Bilezikjian LM,
Gold LH,
Chen R,
Marchuk Y,
Hauser C,
Bentley CA,
Sawchenko PE,
Koob GF,
Vale W,
and
Lee KF.
Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development.
Neuron
20:
1093-1102,
1998[Web of Science][Medline].
37.
Sun, M-K,
and
Guyenet P.
Excitation of rostral medullary pacemaker neurons with putative sympathoexcitatory function by cyclic AMP and
-adrenoceptor agonists in vitro.
Brain Res
511:
30-40,
1990[Web of Science][Medline].
38.
Takahashi, K,
Ghatei MA,
Jones PM,
Murphy JK,
Lam HC,
O'Halloran DJ,
and
Bloom SR.
Endothelin in human brain and pituitary gland: presence of immunoreactive endothelin, endothelin messenger ribonucleic acid, and endothelin receptors.
J Clin Endocrinol Metab
72:
693-699,
1991
39.
Timpl, P,
Spanagel R,
Sillaber I,
Kresse A,
Reul JM,
Stalla GK,
Blanquet V,
Steckler T,
Holsboer F,
and
Wurst W.
Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.
Nat Gen
19:
162-166,
1998[Web of Science][Medline].
40.
Van de Kar, LD,
and
Blair ML.
Forebrain pathways mediating stress-induced hormone secretion.
Front Neuroendocrinol
20:
1-48,
1999[Web of Science][Medline].
41.
Webb, DJ,
Monge JL,
Rabelink TJ,
and
Yanagisawa M.
Endothelin: new discoveries and rapid progress in the clinic.
Trends Pharmacol Sci
19:
5-8,
1998[Medline].
42.
Yanagisawa, M,
Kurihara H,
Kimura S,
Tomobe Y,
Kobayashi M,
Mitsui Y,
Yazaki Y,
Goto K,
and
Masaki T.
A novel potent vasoconstrictor peptide produced by vascular endothelial cells.
Nature
332:
411-415,
1988[Medline].
43.
Yoshizawa, T,
Shinmi O,
Giaid A,
Yanagisawa M,
Gibson SJ,
Kimura S,
Uchiyama Y,
Polak JM,
Masaki T,
and
Kanazawa I.
Endothelin: a novel peptide in the posterior pituitary system.
Science
247:
462-464,
1990
44.
Zhu, B,
and
Herbert J.
Behavioural, autonomic and endocrine responses associated with c-fos expression in the forebrain and brainstem after intracerebroventricular infusions of endothelins.
Neuroscience
71:
1049-1062,
1996[Web of Science][Medline].
This article has been cited by other articles:
![]() |
Y. Kayaba, A. Nakamura, Y. Kasuya, T. Ohuchi, M. Yanagisawa, I. Komuro, Y. Fukuda, and T. Kuwaki Attenuated defense response and low basal blood pressure in orexin knockout mice Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R581 - R593. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Coe, S. J. Haleen, K. M. Welch, Y.-A. Liu, and F. Coceani The Endothelin A Receptor Antagonists PD 156707 (CI-1020) and PD 180988 (CI-1034) Reverse the Hypoxic Pulmonary Vasoconstriction in the Perinatal Lamb J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 672 - 680. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |